Registered outcomes13

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

1 to 13 of 13

List	Outcome	Time frame
Primary	Change in the blood ammonia levels at 5 days of starting therapy in both groups.	Day 5
Secondary	Change in the grading of Hepatic Encephalopathy in both groups.	Day 28
Secondary	Change in the grading of Hepatic Encephalopathy in both groups.	Day 90
Secondary	Proportion of children with worsening ascites in both groups.	Day 28
Secondary	Proportion of children with worsening ascites in both groups.	Day 90
Secondary	Proportion of children with hypernatremia in both groups.	Day 28
Secondary	Proportion of children with hypernatremia in both groups.	Day 90
Secondary	Proportion of children with metabolic acidosis in both groups.	Day 28
Secondary	Proportion of children with metabolic acidosis in both groups.	Day 90
Secondary	Duration of hospital stay in both groups.	Day 28
Secondary	Duration of hospital stay in both groups.	Day 90
Secondary	Short term survival with native liver in both groups	Day 28
Secondary	Short term survival with native liver in both groups	Day 90

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04022941/registered